NRC Health (NRC) Stock Analysis

Company Overview

National Research Corporation operates within the Healthcare sector, specifically serving the Health Information Services industry by providing analytics and insights designed to measure and improve patient and employee experiences for organizations across the United States. The company's operational focus involves delivering market experience solutions and subscription-based services that facilitate improved tracking of awareness, perception, and engagement metrics. In terms of scale, the entity holds a market capitalization of $389.65M and employs 357 individuals to support its operational infrastructure. This market capitalization, combined with a reported annual revenue of $137.39M, positions the company as a mid-cap entity within its specialized niche, suggesting a business model that relies on recurring revenue streams from subscription services rather than one-time transactional sales. The employee count of 357 indicates a relatively lean organizational structure relative to the revenue generated, which is typical for technology and information services firms where software and data analytics drive value creation rather than heavy physical asset deployment.

Financial Health

The company reported a Total Revenue of $137.39M over the trailing twelve months, generating a Net Income of $11.29M and an EBITDA of $37.00M during the same period. The significant gap between the $137.39M revenue and the $11.29M net income reveals a cost structure where approximately 91.6% of revenue is consumed by costs before taxes, resulting in a Net Profit Margin of 8.4%. Free Cash Flow stands at $16.65M, which indicates that the company generates sufficient cash after capital expenditures to fund operations, pay down debt, or potentially return capital to shareholders, although the high payout ratio complicates this picture. The Gross Margin is recorded at 61.9%, reflecting the high-margin nature of providing software and data analytics services, while the Operating Margin of 32.2% and Profit Margin of 8.4% demonstrate the efficiency of the company's overhead management relative to its gross profits. On the balance sheet, the company holds $4.14M in cash against $80.24M in total debt, resulting in a Debt to Equity ratio of 573.55, which characterizes the balance sheet as highly leveraged with cash reserves that are insufficient to cover current debt obligations without external financing. This leverage is further highlighted by a Current Ratio of 0.55, indicating that the company possesses only 55 cents of current assets for every dollar of current liabilities, which suggests tight short-term liquidity conditions. Return on Equity is an impressive 51.2%, while Return on Assets is 13.7%, metrics that reveal management's effectiveness in generating returns on the capital invested, particularly considering the high equity multiplier inherent in the company's capital structure.

Valuation Assessment

Valuation metrics show a Trailing P/E Ratio of 34.26 compared to a Forward P/E of 14.77, implying that the market expects earnings to recover significantly or grow rapidly in the future to justify the lower forward multiple. The Price to Book ratio stands at 27.72, indicating a substantial market premium over the company's tangible book value, which is typical for companies with significant intangible assets like software and data licenses. Alternative valuation metrics include a Price to Sales ratio of 2.84 and an EV/EBITDA of 12.59, suggesting that investors are willing to pay a premium for the company's revenue and earnings power despite the current earnings contraction. Price action over the last year shows a 52-Week High of $22.79 and a 52-Week Low of $9.76, placing the stock's current trading price within a wide historical range that reflects recent volatility. The stock exhibits a Beta of 0.58, which means its price volatility is less than 42% of the broader market's movements, suggesting it acts as a defensive holding relative to the overall market index.

Growth & Income

Recent performance data indicates a Revenue Growth of -4.6% and an Earnings Growth of -74.4% year-over-year, demonstrating that earnings are contracting at a much faster rate than revenue is declining. This divergence suggests that fixed costs or margin compression are disproportionately affecting profitability compared to top-line revenue impacts. The company currently pays a Dividend Yield of 3.3% with a Payout Ratio of 104.0%, indicating that the dividend paid exceeds the annual net income, which raises concerns regarding the sustainability of the payout given the recent earnings decline. Given the payout ratio exceeding 100%, the company is effectively using cash reserves or external financing to maintain the dividend rather than reinvesting all earnings for growth. The overall growth and income profile presents a complex picture of a company generating positive cash flow and high returns on equity while simultaneously experiencing significant earnings contraction and maintaining an unsustainable dividend payout relative to its current profitability.